Key result
Early VA-ECMO plus IABP enables full recovery in fulminant myocarditis with recurrent cardiac arrest.
Why the study?
Fulminant myocarditis is a severe cardiac condition with rapid progression and high mortality, and the role of mechanical circulatory support in improving outcomes is important to illustrate.
Case Report (n=1)
No
Early combined use of VA-ECMO and IABP, alongside immunomodulation, successfully supported a patient in cardiogenic shock and recurrent cardiac arrest secondary to fulminant myocarditis.
Answers are grounded in this paper and cite their sources.
May support early dual MCS in fulminant myocarditis arrest; leaves open need for prospective trials.
BACKGROUND: Fulminant myocarditis is a severe cardiac condition characterized by rapid progression and high mortality. In recent years, advancements in medical technology, particularly the application of mechanical circulatory support, have significantly improved patient outcomes. CASE PRESENTATION: A 36-year-old male patient was admitted with a history of “fever for 5 days and chest tightness and pain for 2 days”.He was diagnosed with acute myocarditis and subsequently experienced cardiac arrest. After resuscitation, he was transferred to the medical ICU, where he received VA-ECMO and IABP support therapy, eventually recovering and being discharged. CONCLUSION: Early recognition, timely intervention, and mechanical circulatory support are crucial in the treatment of fulminant myocarditis, significantly enhancing patient survival rates.
No takes yet. Share an insight, caveat, or question.
He et al. (2026) conducted a case report in Fulminant myocarditis complicated by cardiac arrest (n=1). VA-ECMO combined with IABP was evaluated on Survival and clinical recovery. Early initiation of VA-ECMO combined with IABP led to successful recovery and hospital discharge in a patient with fulminant myocarditis and recurrent cardiac arrest.
Synapse has enriched 10 related papers. Consider them for comparative context: